404
+1-313-307-4176
Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Report
Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Trends & Market Insights
Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market, By Type (Services, Assay kits, System), Application (Hospital, Clinic), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
The global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of around x% during the forecast period.
Wish to get a free sample? Register Here
Human papillomavirus infection (HPV infection) is an infection caused by human papillomavirus (HPV), a DNA virus from the Papillomaviridae family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. The equipment used to diagnose molecular HPV infection includes services, assay kits, and a system.
Key players operating in the Molecular Human Papillomavirus (HPV) Diagnostic Equipment market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Qiagen (Germany), Thermo Fisher Scientific (US), Abbott Laboratories (US), Hologic, Inc. (US), Cepheid (US), SEEGENE (South Korea), Takara Bio Inc. (Japan), Daan Gene (China), Promega Corporation (US), Greiner Bio-One International GmbH (Austria), Enzo Biochem, Inc. (US), Norgen Biotek Corp. (Canada), DiagCor Bioscience Incorporation Limited (HongKong), Guangdong Hybribio (China), ZytoVision GmbH (Germany), Arbor Vita Corporation (US) and Medical & Biological Laboratories Co., Ltd. (Japan).
The growth of the Molecular Human Papillomavirus (HPV) Diagnostic Equipment market is primarily driven by increasing incidences of cervical cancer. Cervical cancer is among the most common cancers among women above the age of 40. According to estimates from the WHO, cervical cancer is the fourth most frequent cancer, with approximately 570,000 cases and over 311,000 deaths in 2018. In addition to this, surging demand for advanced molecular HPV diagnostic equipment is likely to create lucrative opportunities for the players operating in the global market in the coming years.
By application, the molecular human papillomavirus (HPV) diagnostic equipment market has been bifurcated into hospitals and clinics. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of required infrastructure and skilled healthcare professionals.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the high demand for advanced HPV diagnostic equipment coupled with the presence of key market players such as Agilent Technologies, Inc. (US) and Becton, Dickinson, and Company (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing prevalence of sexually transmitted diseases.
The outbreak of the COVID-19 virus posed significant challenges to the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product demand and supply for a short period.
Here is the list of the group of customers that the molecular human papillomavirus diagnostic equipment market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Increasing incidences of cervical cancer is the prime factor driving the growth of molecular HPV diagnostic equipment market.
The hospitals' segment is expected to register the significant growth in the molecular HPV diagnostic equipment market in the coming years.
North America accounted for the largest share in the molecular HPV diagnostic equipment market in 2020.
Molecular human papillomavirus (HPV) diagnostic equipment distributors, Molecular human papillomavirus (HPV) diagnostic equipment suppliers, Molecular human papillomavirus (HPV) diagnostic equipment manufacturers, Logistics organizations, Government bodies are the target audience in the molecular HPV diagnostic equipment market.
WE ACCEPT
